{"id":93866,"date":"2005-05-27T06:00:00","date_gmt":"2005-05-27T04:00:00","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/news-posts\/directpharmakeia-rozwiazanie-dla-farmacji\/"},"modified":"2005-05-27T06:00:00","modified_gmt":"2005-05-27T04:00:00","slug":"directpharmakeia-rozwiazanie-dla-farmacji","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/marketing\/pr\/directpharmakeia-rozwiazanie-dla-farmacji.html","title":{"rendered":"Directpharmak\u00e9ia &#8211; rozwi\u0105zanie dla farmacji"},"content":{"rendered":"<p><P>farmaceutycznej. Zamiast tradycyjnego listu ofertowego zorganizowano akcj\u0119 DirectPharmak\u00e9ia w ramach projektu Pogotowie CTM.<\/P><br \/>\n<P>Ide\u0105 DirectPharmak\u00e9ia jest promowanie wielokana\u0142owej komunikacji poprzez zintegrowanie narz\u0119dzi proponowanych przez contact center. Odwr\u00f3cenie r\u00f3l pomi\u0119dzy CTM a grup\u0105 odbiorc\u00f3w pozwala na czynny udzia\u0142 w akcji, na wypr\u00f3bowanie narz\u0119dzi i sprawdzenie ich skuteczno\u015bci. W tym celu zosta\u0142 przygotowany w zabawnej formie list zach\u0119caj\u0105cy do wsp\u00f3\u0142pracy oraz ulotka informacyjna o korzy\u015bciach wynikaj\u0105cych ze stosowania &#8222;leku&#8221; DirectPharmak\u00e9ia. <\/P><br \/>\n<P>Projekt Pogotowie CTM w ramach kt\u00f3rego dzia\u0142a DirectPharmak\u00e9ia wykorzystuje min. takie narz\u0119dzia w kontaktach z odbiorcami jak: portal produktowy <A href=\"http:\/\/www.999ctm.pl\">www.999ctm.pl<\/A>, infolini\u0119 0 801 999 CTM i mail <A href=\"mailto:pogotowie@ctm.pl\">pogotowie@ctm.pl<\/A>.<\/P><\/p>\n","protected":false},"excerpt":{"rendered":"CTM Teleperformance Polska i Press Room studio PR opracowa\u0142y niekonwencjonalny projekt skierowany do bran\u017cy","protected":false},"author":1,"featured_media":93867,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[9648],"tags":[],"class_list":{"0":"post-93866","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-pr","8":"cs-entry","9":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/93866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=93866"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/93866\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media\/93867"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=93866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=93866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=93866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}